Patents by Inventor Tobias Merkle

Tobias Merkle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11997280
    Abstract: An apparatus includes an encoder, which receives image or video data, encodes the data and provides a bitstream representing the data. The encoder includes a CABAC encoder, which receives a binary valued syntax element associated with a block of the data to be encoded, and encodes, using a selected context model, the syntax element into coded bits for the bitstream. The syntax element includes a tool flag indicating whether or not certain coding tool, like linear weighted intra prediction, is employed when encoding a block of the data. For a block of the data which exhibits an aspect ratio larger than 2 and for a block of the data which exhibits an aspect ratio less than or equal to 2, and to which blocks the certain coding tool is applicable, first and second context models for encoding the tool flag are selected from a group of one or more first and second context models, respectively.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: May 28, 2024
    Assignee: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
    Inventors: Jonathan Pfaff, Philipp Helle, Michael Schäfer, Tobias Hinz, Björn Stallenberger, Philipp Merkle, Heiko Schwarz, Detlev Marpe, Thomas Wiegand
  • Publication number: 20220073915
    Abstract: The present invention concerns artificial nucleic acids for site-directed editing of a target RNA. In particular, the present invention provides artificial nucleic acids capable of site-directed editing of endogenous transcripts by harnessing an endogenous deaminase. Further, the present invention provides artificial nucleic acids for sited-directed editing of a target RNA, which are chemically modified, in particular according to a modification pattern as described herein. The invention also comprises a vector encoding said artificial nucleic acid and a composition comprising said artificial nucleic acid. Moreover, the invention provides the use of the artificial nucleic acid, the composition or the vector for site-directed editing of a target RNA or for in vitro diagnosis. In addition, the artificial nucleic acid, the composition or the vector as described herein are provided for use as a medicament or for use in diagnosis of a disease or disorder.
    Type: Application
    Filed: June 29, 2018
    Publication date: March 10, 2022
    Inventors: Jacqueline Wettengel, Thorsten Stafforst, Philipp Reautschnig, Tobias Merkle